Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Bubić I[au]:

Search results

Items: 33

1.

Patients with sentinel lymph node positive melanoma: Who needs completion lymph node dissection?

Schuitevoerder D, Bubic I, Fortino J, Massimino KP, Vetto JT.

Am J Surg. 2018 May;215(5):868-872. doi: 10.1016/j.amjsurg.2018.01.033. Epub 2018 Feb 15.

PMID:
29397888
2.

The European Renal Association - European Dialysis and Transplant Association Registry Annual Report 2014: a summary.

Pippias M, Kramer A, Noordzij M, Afentakis N, Alonso de la Torre R, Ambühl PM, Aparicio Madre MI, Arribas Monzón F, Åsberg A, Bonthuis M, Bouzas Caamaño E, Bubic I, Caskey FJ, Castro de la Nuez P, Cernevskis H, de Los Ángeles Garcia Bazaga M, des Grottes JM, Fernández González R, Ferrer-Alamar M, Finne P, Garneata L, Golan E, Heaf JG, Hemmelder MH, Idrizi A, Ioannou K, Jarraya F, Kantaria N, Kolesnyk M, Kramar R, Lassalle M, Lezaic VV, Lopot F, Macario F, Magaz Á, Martín de Francisco AL, Martín Escobar E, Martínez Castelao A, Metcalfe W, Moreno Alia I, Nordio M, Ots-Rosenberg M, Palsson R, Ratkovic M, Resic H, Rutkowski B, Santiuste de Pablos C, Seyahi N, Fernanda Slon Roblero M, Spustova V, Stas KJF, Stendahl ME, Stojceva-Taneva O, Vazelov E, Ziginskiene E, Massy Z, Jager KJ, Stel VS.

Clin Kidney J. 2017 Apr;10(2):154-169. doi: 10.1093/ckj/sfw135. Epub 2017 Jan 16.

3.

Renal replacement therapy in Europe: a summary of the 2013 ERA-EDTA Registry Annual Report with a focus on diabetes mellitus.

Kramer A, Pippias M, Stel VS, Bonthuis M, Abad Diez JM, Afentakis N, Alonso de la Torre R, Ambuhl P, Bikbov B, Bouzas Caamaño E, Bubic I, Buturovic-Ponikvar J, Caskey FJ, Castro de la Nuez P, Cernevskis H, Collart F, Comas Farnés J, Garcia Bazaga Mde L, De Meester J, Ferrer Alamar M, Finne P, Garneata L, Golan E, G Heaf J, Hemmelder M, Ioannou K, Kantaria N, Kolesnyk M, Kramar R, Lassalle M, Lezaic V, Lopot F, Macário F, Magaz A, Martín-Escobar E, Metcalfe W, Ots-Rosenberg M, Palsson R, Piñera Celestino C, Resić H, Rutkowski B, Santiuste de Pablos C, Spustová V, Stendahl M, Strakosha A, Süleymanlar G, Torres Guinea M, Varberg Reisæter A, Vazelov E, Ziginskiene E, Massy ZA, Wanner C, Jager KJ, Noordzij M.

Clin Kidney J. 2016 Jun;9(3):457-69. doi: 10.1093/ckj/sfv151. Epub 2016 Jan 31.

4.

[Treatment of anemia in chronic kidney disease--position statement of the Croatian Society for Nephrology, Dialysis and Transplantation and review of the KDIGO and ERPB guidelines].

Rački S, Bašić-Jukić N, Kes P, Ljutić D, Lovčić V, Prkačin I, Radić J, Vujičić B, Bubić I, Jakić M, Belavić Ž, Sefer S, Pehai M, Klarić D, Gulin M; Croatian Society for Nephrology, Dialysis and Transplantation.

Acta Med Croatica. 2014 Apr;68(2):215-21. Croatian.

PMID:
26012163
5.

[Consensus statement of the Croatian Society for Nephrology, Dialysis and Transplantation regarding the use of generic immunosuppressive drugs].

Bašić-Jukić N, Rački S, Knotek M, Bubić-Filipi L, Bubić I, Zibar L, Kes P; Croatian Society for Nephrology, Dialysis and Transplantation.

Acta Med Croatica. 2014 Apr;68(2):211-4. Croatian.

PMID:
26012162
6.

[Assessment of nutritional status in patients with chronic kidney disease on maintance hemodialysis].

Mikolašević I, Orlić L, Vidrih S, Poje B, Bubić I, Vujičić B, Rački S.

Acta Med Croatica. 2014 Apr;68(2):97-102. Croatian.

PMID:
26012145
7.

Survival of chronic hemodialysis patients over 80 years of age.

Sladoje-Martinovic B, Mikolasevic I, Bubic I, Racki S, Orlic L.

Clin Interv Aging. 2014 Apr 16;9:689-96. doi: 10.2147/CIA.S58976. eCollection 2014.

8.

Acute antibody-mediated rejection of the kidney transplant - experience of a single center in Croatia.

Orlić L, Sladoje-Martinović B, Mikolašević I, Pavletić Peršić M, Bubić I, Jelić I, Rački S.

Med Glas (Zenica). 2014 Feb;11(1):138-44.

PMID:
24496355
9.

BCM--body composition monitor: a new tool for the assessment of volume-dependent hypertension in patients on maintenance haemodialysis.

Vujicić B, Mikolasević I, Racki S, Orlić L, Ljutić D, Bubić I.

Coll Antropol. 2013 Sep;37(3):815-9.

PMID:
24308222
10.

Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the early period after kidney transplantation.

Orlić L, Mikolasević I, Sladoje-Martinović B, Bubić I, Pavletić-Persić M, Racki S.

Coll Antropol. 2013 Sep;37(3):809-14.

PMID:
24308221
11.

Chronic kidney disease and nonalcoholic Fatty liver disease proven by transient elastography.

Mikolasevic I, Racki S, Bubic I, Jelic I, Stimac D, Orlic L.

Kidney Blood Press Res. 2013;37(4-5):305-10. doi: 10.1159/000350158. Epub 2013 Sep 12.

12.

[Long term survival patient on hemodialysis--case report].

Orlić L, Sladoje-Martinović B, Cosić SZ, Maleta I, Vuksanović-Mikulicić S, Bubić I, Pavletić-Persić M, Racki S.

Acta Med Croatica. 2012 Oct;66 Suppl 2:81-4. Croatian.

PMID:
23513423
13.

[Efficacy and safety of CERA in anemia correction in predialysis patients--Croatian experience].

Bubić I, Prkacin I, Racki S.

Acta Med Croatica. 2012 Oct;66 Suppl 2:42-6. Croatian.

PMID:
23513415
14.

[Clinical relevance of anemia treatment in patients with chronic kidney disease].

Vuksanović-Mikulicić S, Mikolasević I, Jelić I, Bubić I, Sladoje-Martinović B, Racki S.

Acta Med Croatica. 2012 Jul;66(3):193-202. Croatian.

PMID:
23441533
15.

Mycophenolate mofetil induced severe, life threatening lower gastrointestinal bleeding - case report.

Hauser G, Bubic I, Vlahovic-Palcevski V, Spanjol J, Stimac D.

Nefrologia. 2013 Jan 18;33(1):146-7. doi: 10.3265/Nefrologia.pre2012.Jun.11512. No abstract available.

16.

Dominant-negative FADD rescues the in vivo fitness of a cytomegalovirus lacking an antiapoptotic viral gene.

Cicin-Sain L, Ruzsics Z, Podlech J, Bubić I, Menard C, Jonjić S, Reddehase MJ, Koszinowski UH.

J Virol. 2008 Mar;82(5):2056-64. Epub 2007 Dec 19.

17.

Targeted deletion of regions rich in immune-evasive genes from the cytomegalovirus genome as a novel vaccine strategy.

Cicin-Sain L, Bubić I, Schnee M, Ruzsics Z, Mohr C, Jonjić S, Koszinowski UH.

J Virol. 2007 Dec;81(24):13825-34. Epub 2007 Oct 3.

18.

Cmv4, a new locus linked to the NK cell gene complex, controls innate resistance to cytomegalovirus in wild-derived mice.

Adam SG, Caraux A, Fodil-Cornu N, Loredo-Osti JC, Lesjean-Pottier S, Jaubert J, Bubic I, Jonjic S, Guénet JL, Vidal SM, Colucci F.

J Immunol. 2006 May 1;176(9):5478-85.

19.

Novel functions of tyrosine kinase 2 in the antiviral defense against murine cytomegalovirus.

Strobl B, Bubic I, Bruns U, Steinborn R, Lajko R, Kolbe T, Karaghiosoff M, Kalinke U, Jonjic S, Müller M.

J Immunol. 2005 Sep 15;175(6):4000-8.

20.

A cytomegaloviral protein reveals a dual role for STAT2 in IFN-{gamma} signaling and antiviral responses.

Zimmermann A, Trilling M, Wagner M, Wilborn M, Bubic I, Jonjic S, Koszinowski U, Hengel H.

J Exp Med. 2005 May 16;201(10):1543-53. Epub 2005 May 9.

21.

Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoprotein.

Hasan M, Krmpotic A, Ruzsics Z, Bubic I, Lenac T, Halenius A, Loewendorf A, Messerle M, Hengel H, Jonjic S, Koszinowski UH.

J Virol. 2005 Mar;79(5):2920-30.

22.

NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145.

Krmpotic A, Hasan M, Loewendorf A, Saulig T, Halenius A, Lenac T, Polic B, Bubic I, Kriegeskorte A, Pernjak-Pugel E, Messerle M, Hengel H, Busch DH, Koszinowski UH, Jonjic S.

J Exp Med. 2005 Jan 17;201(2):211-20. Epub 2005 Jan 10.

23.

Gain of virulence caused by loss of a gene in murine cytomegalovirus.

Bubić I, Wagner M, Krmpotić A, Saulig T, Kim S, Yokoyama WM, Jonjić S, Koszinowski UH.

J Virol. 2004 Jul;78(14):7536-44.

24.

Escape of mutant double-stranded DNA virus from innate immune control.

French AR, Pingel JT, Wagner M, Bubic I, Yang L, Kim S, Koszinowski U, Jonjic S, Yokoyama WM.

Immunity. 2004 Jun;20(6):747-56.

25.

Pathogenesis of murine cytomegalovirus infection.

Krmpotic A, Bubic I, Polic B, Lucin P, Jonjic S.

Microbes Infect. 2003 Nov;5(13):1263-77. Review.

PMID:
14623023
26.

Vaccination of mice with bacteria carrying a cloned herpesvirus genome reconstituted in vivo.

Cicin-Sain L, Brune W, Bubic I, Jonjic S, Koszinowski UH.

J Virol. 2003 Aug;77(15):8249-55.

27.

MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo.

Krmpotić A, Busch DH, Bubić I, Gebhardt F, Hengel H, Hasan M, Scalzo AA, Koszinowski UH, Jonjić S.

Nat Immunol. 2002 Jun;3(6):529-35. Epub 2002 May 20.

PMID:
12021778
28.

Secreted virus-encoded proteins reflect murine cytomegalovirus productivity in organs.

Brune W, Hasan M, Krych M, Bubić I, Jonjić S, Koszinowski UH.

J Infect Dis. 2001 Nov 15;184(10):1320-4. Epub 2001 Oct 29.

PMID:
11679922
29.

[Phylogenetic study of intramural coronary vessels].

Sećerov D, Bubić I.

Med Arh. 1981;35(5-6):249-52. Croatian. No abstract available.

PMID:
7345268
30.

[Isolated heart and blood vessels with their nerves as a pharmacologic research tool].

Hukovic S, Bubic I.

Pathol Biol. 1967 Feb;15(3):153-7. French. No abstract available.

PMID:
4860726
31.

[EFFECT OF CHOLINESTERASE ANTAGONISTS AND ATROPINE ON ISOLATED ATROPINE-RESISTANT RAT AND MOUSE ORGANS].

HUKOVIC S, BUBIC I.

Acta Med Iugosl. 1963;17:300-20. Undetermined Language. No abstract available.

PMID:
14182419
32.
33.

How to determine a "dangerous temporal bone".

HADZISELIMOVIC H, SAVKOVIC L, BUBIC I.

Acta Anat (Basel). 1961;44:322-35. No abstract available.

PMID:
13710372

Supplemental Content

Support Center